Highly active antiretroviral therapy

被引：2
作者：
Murri, R [1 ]
机构：
[1] Univ Cattolica Sacro Cuore, Dept Infect Dis, I-00168 Rome, Italy
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2005年 / 330卷 / 7493期
关键词：
D O I：
10.1136/bmj.330.7493.681
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：681 / 682
页数：2
相关论文
共 12 条
  • [1] Ammassari A, 2001, J ACQ IMMUN DEF SYND, V28, P445, DOI 10.1097/00042560-200112150-00006
  • [2] [Anonymous], 1998, MMWR-MORBID MORTAL W, V47, P1
  • [3] How does expert advice impact genotypic resistance testing in clinical practice?
    Badri, SM
    Adeyemi, OM
    Max, BE
    Zagorski, BM
    Barker, DE
    [J]. CLINICAL INFECTIOUS DISEASES, 2003, 37 (05) : 708 - 713
  • [4] Modeling the HIV protease inhibitor adherence-resistance curve by use of empirically derived estimates
    Bangsberg, DR
    Porco, TC
    Kagay, C
    Charlebois, ED
    Deeks, SG
    Guzman, D
    Clark, R
    Moss, A
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (01) : 162 - 165
  • [5] Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count
    García, F
    de Lazzari, E
    Plana, M
    Castro, P
    Mestre, G
    Nomdedeu, M
    Fumero, E
    Martínez, E
    Mallolas, J
    Blanco, JL
    Miró, JM
    Pumarola, T
    Gallart, T
    Gatell, JM
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 36 (02) : 702 - 713
  • [6] Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy
    Hunt, PW
    Deeks, SG
    Rodriguez, B
    Valdez, H
    Shade, SB
    Abrams, DI
    Kitahata, MM
    Krone, M
    Neilands, TB
    Brand, RJ
    Lederman, MM
    Martin, JN
    [J]. AIDS, 2003, 17 (13) : 1907 - 1915
  • [7] Justice A C, 1999, J Acquir Immune Defic Syndr, V21, P126
  • [8] Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes
    Ledergerber, B
    Lundgren, JD
    Walker, AS
    Sabin, C
    Justice, A
    Reiss, P
    Mussini, C
    Wit, F
    Monforte, AD
    Weber, R
    Fusco, G
    Staszewski, S
    Law, M
    Hogg, R
    Lampe, F
    Gill, MJ
    Castelli, F
    Phillips, AN
    Castelli, F
    Fusco, GP
    Gill, MJ
    Hogg, R
    Lampe, F
    Law, M
    Ledergerber, B
    Lundgren, JD
    Monforte, AD
    Mussini, C
    Phillips, AN
    Reiss, P
    Staszewski, S
    Walker, AS
    Rooney, P
    Taylor, S
    Couldwell, D
    Austin, D
    Block, M
    Clemons, J
    Finlayson, R
    Law, M
    Petoumenos, K
    Quan, D
    Smith, D
    O'Connor, C
    Gorton, C
    Allen, D
    Mulhall, B
    Mutimer, K
    Smith, D
    Keeffe, N
    [J]. LANCET, 2004, 364 (9428) : 51 - 62
  • [9] Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients
    Monforte, AD
    Lepri, AC
    Rezza, G
    Pezzotti, P
    Antinori, A
    Phillips, AN
    Angarano, G
    Colangeli, V
    De Luca, A
    Ippolito, G
    Caggese, L
    Soscia, F
    Filice, G
    Gritti, F
    Narciso, P
    Tirelli, U
    Moroni, M
    [J]. AIDS, 2000, 14 (05) : 499 - 507
  • [10] Effect of persistent moderate viremia on disease progression during HIV therapy
    Raffanti, SP
    Fusco, JS
    Sherrill, BH
    Hansen, NI
    Justice, AC
    D' Aquila, R
    Mangialardi, WJ
    Fusco, GP
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 37 (01) : 1147 - 1154
12